COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
Abstract Part II
See Part I of this study here.
The COVID-19 modified mRNA (modmRNA) lipid nanoparticle-based “vaccines” are not classical antigen-based vaccines but instead prodrugs informed by gene therapy technology. Of considerable note, these products have been linked …
The post COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2 appeared first on Global Research.
Read More
The circulation of H5N1 bird flu in animals and limited infections in humans have motivated flu preparedness activities, such as stockpiling vaccines. Social media posts have baselessly implied that these efforts are evidence that a new laboratory-derived version of the virus is going to cause a pandemic — or even that there is a conspiracy to release bird flu from a lab.
